Skip to main content
SpringerLink
Log in

Targeted cancer therapies struggle in Mexico and Brazil

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The Impact of LATAM (Brazil and Mexico) Payer Policy on Prescribing in Non-Hodgkin's Lymphoma and Multiple Myeloma

Reference

  • Decision Resources. Coverage of Novel Therapies for Non-Hodgkin's Lymphoma and Multiple Myeloma in Brazil and Mexico Hinges on Demonstrating Clinical and Economic Benefit Versus MabThera and Velcade. Media Release : 9 Jun 2014. Available from: URL: http://www.decisionresourcesgroup.com

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Targeted cancer therapies struggle in Mexico and Brazil. PharmacoEcon Outcomes News 705, 11 (2014). https://doi.org/10.1007/s40274-014-1335-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1335-8

Search

Navigation